Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands

Cancer Research

Volumn 63, Issue 18, 2003, Pages 6090-6095

  Niho, Naoko ^a   Takahashi, Mami ^a   Kitamura, Tomohiro ^a   Shoji, Yutaka ^a   Itoh, Masaki ^b,c   Noda, Tetsuo ^b,d   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b CANCER INSTITUTE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BEZAFIBRATE; CHOLESTEROL; LIPID; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; FEMALE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; LIPID BLOOD LEVEL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEATOSIS; TUMOR GROWTH;

AGE FACTORS; ANIMALS; BEZAFIBRATE; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; GENES, APC; HYPERLIPIDEMIAS; INTESTINAL POLYPOSIS; INTESTINE, SMALL; LIGANDS; LIPOPROTEIN LIPASE; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0141842617     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bruce, W. R., Wolever, T. M., and Giacca, A. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr. Cancer, 37: 19-26, 2000.
2. McKeown-Eyssen, G. E. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomark. Prev., 3: 687-695, 1994.
3. Jarvinen, R., Knekt, P., Hakulinen, T., Rissanen, H., and Heliovaara, M. Dietary fat, cholesterol and colorectal cancer in a prospective study. Br. J. Cancer, 85: 357-361, 2001.
4. Agarwal, B., Rao, C. V., Bhendwal, S., Ramey, W. R., Shirin, H., Reddy, B. S., and Holt, P. R. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology, 117, 838-847, 1999.
5. Schoonjans, K., Staels, B., and Auwerx, J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta, 1302: 93-109, 1996.
6. Rosen, E. D., and Spiegelman, B. M. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem., 276: 37731-37734, 2001.
7. Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA, 94: 237-241, 1997.
8. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., and Spiegelman, B. M. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med., 4: 1046-1052, 1998.
9. Suh, N., Wang, Y., Williams, C. R., Risingsong, R., Gilmer, T., Willson, T. M., and Spom, M. B. A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis. Cancer Res., 59: 5671-5673, 1999.
10. Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X. P., Eng, C., Spiegelman, B. M., and Kantoff, P. W. Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer. Proc. Natl. Acad. Sci. USA. 97: 10990-10995, 2000.
11. Inoue, K., Kawahito, Y., Tsubouchi, Y., Kohno, M., Yoshimura, R., Yoshikawa, T., and Sano, H. Expression of peroxisome proliferator-activated receptor γ in renal cell carcinoma and growth inhibition by its agonists. Biochem. Biophys. Res. Commun., 287: 727-732, 2001.
12. Rumi, M., Sato, H., Ishihara, S., Kawashima, K., Hamamoto, S., Kazumori, H., Okuyama, T., Fukuda, R., Nagasue, N., and Kinoshita, Y. Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma. Br. J. Cancer, 84: 1640-1647, 2001.
13. Takahashi, N., Okumura, T., Motomura, W., Fujimoto, Y., Kawabata, I., and Kohgo, Y. Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS. Lett., 455, 135-139, 1999.
14. Begum, N. M., Nakashiro, K., Kawamata, H., Uchida, D., Shintani, S., Ikawa, Y., Sato, M., and Hamakawa, H. Expression of peroxisome proliferator-activated receptor γ and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines. Int. J. Oncol., 20: 599-605, 2002.
15. Pighetti, G. M., Novosad, W., Nicholson, C., Hitt, D. C., Hansens, C., Hollingsworth, A. B., Lemer, M. L., Brackett, D., Lightfoot, S. A., and Gimbl, J. M. Therapeutic treatment of DMBA-induced mammary tumors with PPAR ligands. Anticancer Res., 21: 825-829, 2001.
16. Sakamoto, J., Kimura, H., Moriyama, S., Odaka, H., Momose, Y., Sugiyama, Y., and Sawada, H. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem. Biophys. Res. Commun., 278: 704-711, 2000.
17. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., and Auwerx, J. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J., 15: 5336-5348, 1996.
18. Tanaka, T., Kohno, H., Yoshitani, S., Takashima, S., Okumura, A., Murakami, A., and Hosokawa, M. Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res., 61: 2424-2428, 2001.
19. Min/+ mice. Nat. Med., 4: 1053-1057, 1998.
20. Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G., Ming, U. T., Baird, S. M., Thomazy, V. A., and Evans, R. M. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat. Med., 4: 1058-1061, 1998.
21. Quesada, C. F., Kimata, H., Mori, M., Nishimura, M., Tsuneyoshi, T., and Baba, S. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Jpn. J. Cancer Res., 89: 392-396, 1998.
22. Moser, A. R., Pitot, H. C., and Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Wash. DC), 247: 322-324, 1990.
23. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo, M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA, 92: 4482-4486, 1995.
24. Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B., Breukel, C., Alt, E., Lipkin, M., Khan, P. M., and Kucherlapati, R. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA, 91: 8969-8973, 1994.
25. Kitamura, T., Kawamori, T., Uchiya, N., Itoh, M., Noda, T., Matsuura, M., Sugimura, T., and Wakabayashi, K. Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis. Carcinogenesis (Lond.), 23: 1463-1466, 2002.
26. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (Wash. DC), 256: 668-670, 1992.
27. Tamaoku, K., Ueno, K., Akiura, K., and Ohkura, Y. New water-soluble hydrogen donors for the enzymatic photometric determination of hydrogen peroxide. II. N-ethyl-N-(2-hydroxy-3-sulfopropyl)aniline derivatives. Chem. Pharm. Bull., 30: 2492-2497, 1982.
28. Richmond, W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin. Chem., 19: 1350-1356, 1973.
29. Sugo, S., Matsumoto, Y., Yamaoka, T., and Sakurabayashi, I. Improved enzymatic method for determining free fatty acids in serum, with use of 3-octenoic acid. Clin. Chem., 36: 163, 1990.
30. 1 in colon carcinogenesis. Cancer Res., 59: 5093-5096, 1999.
31. Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., and Goldstein, J. L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Investig., 98: 1575-1584, 1996.
32. Fan, C. Y., Pan, J., Chu, R., Lee, D., Kluckman, K. D., Usuda, N., Singh, I., Yeldandi, A. V., Rao, M. S., Maeda, N., and Reddy, J. K. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem., 271: 24698-24710, 1996.
33. Heinzer, A. K., Kemp, S., Lu, J. F., Watkins, P. A., and Smith, K. D. Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy. J. Biol. Chem., 277: 28765-28773, 2002.
34. Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Anoglu, E., Gavrilova, O., and Reitman, M. L. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones., J. Clin. Investig., 106: 1221-1228, 2000.
35. Devine, J. H., Eubank, D. W., Clouthier, D. E., Tontonoz, P., Spiegelman, B. M., Hammer, R. E., and Beale, E. G. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor γ and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J. Biol. Chem., 274: 13604-13612, 1999.
36. Barton, T. P., Cruse, J. P., and Lewin, M. R. Changes in serum lipids related to the presence of experimental colon cancer. Br. J. Cancer, 56: 451-454, 1987.
37. Crawford, H. C., Fingleton, B. M., Rudolph-Owen, L. A., Goss, K. J., Rubinfeld, B., Polakis, P., and Matrisian, L. M. The metaltoproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene, 18: 2883-2891, 1999.
38. Yamada, T., Takaoka, A. S., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., Ochiai, A., and Hirohashi, S. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res., 60: 4761-4766, 2000.
39. Koh, T. J., Bulitta, C. J., Fleming, J. V., Dockray, G. J., Varro, A., and Wang, T. C. Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J. Clin. Investig., 106: 533-539, 2000.
40. Rockman, S. P., Currie, S. A., Ciavarella, M., Vincan, E., Dow, C., Thomas, R. J., and Phillips, W. A. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem., 276: 45113-45119, 2001.
41. Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., and MacDougald, O. A. Inhibition of adipogenesis by Wnt signaling. Science (Wash. DC), 289: 950-953, 2000.
42. Gimun, G. D., Smith, W. M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Rosenberg, D. W., Bronson, R. T., Edelmann, W., Kucherlapati, R., Gonzalez, F. J., and Spiegelman, B. M. APC-dependent suppression of colon carcinogenesis by PPARγ. Proc. Natl. Acad. Sci. USA, 99: 13771-13776, 2002.
43. Chiu, C. H., McEntee, M. F., and Whelan, J. Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice. Prostaglandins Leukot. Essent. Fatty Acids, 62: 269-275, 2000.
44. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., and Kliewer, S. A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J. Biol. Chem., 272, 3406-3410, 1997.
45. Clay, C. E., Namen, A. M., Atsumi, G., Trimboli, A. J., Fonteh, A. N., High, K. P., and Chilton, F. H. Magnitude of peroxisome proliferator-activated receptor-γ activation is associated with important and seemingly opposite biological responses in breast cancer cells. J. Investig. Med., 49: 413-420, 2001.